161 related articles for article (PubMed ID: 11927006)
1. Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.
Saito K; Yagihashi A; Nasu S; Izawa Y; Nakamura M; Kobayashi D; Tsuji N; Watanabe N
Jpn J Cancer Res; 2002 Mar; 93(3):253-8. PubMed ID: 11927006
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen gene expression and telomerase activity in breast cancer patients: possible relationship to steroid hormone receptors.
Mohajeri A; Zarghami N; Pourhasan Moghadam M; Alani B; Montazeri V; Baiat A; Fekhrjou A
Oncol Res; 2011; 19(8-9):375-80. PubMed ID: 22329196
[TBL] [Abstract][Full Text] [Related]
4. Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer.
Miyachi K; Fujita M; Tanaka N; Sasaki K; Sunagawa M
J Exp Clin Cancer Res; 2002 Jun; 21(2):269-75. PubMed ID: 12148588
[TBL] [Abstract][Full Text] [Related]
5. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
6. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Kitadai Y; Haruma K; Chayama K; Tahara E; Yasui W
Pathobiology; 2001; 69(4):219-24. PubMed ID: 12007281
[TBL] [Abstract][Full Text] [Related]
7. Impaired telomere regulation mechanism by TRF1 (telomere-binding protein), but not TRF2 expression, in acute leukemia cells.
Ohyashiki JH; Hayashi S; Yahata N; Iwama H; Ando K; Tauchi T; Ohyashiki K
Int J Oncol; 2001 Mar; 18(3):593-8. PubMed ID: 11179492
[TBL] [Abstract][Full Text] [Related]
8. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Yamada K; Yajima T; Yagihashi A; Kobayashi D; Koyanagi Y; Asanuma K; Yamada M; Moriai R; Kameshima H; Watanabe N
Jpn J Cancer Res; 2000 Dec; 91(12):1278-84. PubMed ID: 11123427
[TBL] [Abstract][Full Text] [Related]
9. Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer.
Hu H; Zhang Y; Zou M; Yang S; Liang XQ
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1407-14. PubMed ID: 20127252
[TBL] [Abstract][Full Text] [Related]
10. Control of telomere length by the human telomeric protein TRF1.
van Steensel B; de Lange T
Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
[TBL] [Abstract][Full Text] [Related]
12. Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2.
Ancelin K; Brunori M; Bauwens S; Koering CE; Brun C; Ricoul M; Pommier JP; Sabatier L; Gilson E
Mol Cell Biol; 2002 May; 22(10):3474-87. PubMed ID: 11971978
[TBL] [Abstract][Full Text] [Related]
13. Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells.
Yajima T; Yagihashi A; Kameshima H; Kobayashi D; Hirata K; Watanabe N
Br J Cancer; 2001 Sep; 85(5):752-7. PubMed ID: 11531263
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in human breast tumors.
Hiyama E; Gollahon L; Kataoka T; Kuroi K; Yokoyama T; Gazdar AF; Hiyama K; Piatyszek MA; Shay JW
J Natl Cancer Inst; 1996 Jan; 88(2):116-22. PubMed ID: 8537972
[TBL] [Abstract][Full Text] [Related]
15. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
16. Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
Poonepalli A; Banerjee B; Ramnarayanan K; Palanisamy N; Putti TC; Hande MP
Genes Chromosomes Cancer; 2008 Dec; 47(12):1098-109. PubMed ID: 18720522
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Relative Telomere Length is Associated With hTERT Gene Expression in the Tissue of Patients With Breast Cancer.
Thriveni K; Raju A; Kumar RV; Krishnamurthy S; Chaluvarayaswamy R
Clin Breast Cancer; 2019 Feb; 19(1):27-34. PubMed ID: 30217473
[TBL] [Abstract][Full Text] [Related]
18. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
19. Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells.
Yamada K; Yagihashi A; Yamada M; Asanuma K; Moriai R; Kobayashi D; Tsuji N; Watanabe N
Anticancer Res; 2002; 22(2B):1315-20. PubMed ID: 12168944
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in normal and neoplastic breast.
Tsao Jl; Zhao Y; Lukas J; Yang X; Shah A; Press M; Shibata D
Clin Cancer Res; 1997 Apr; 3(4):627-31. PubMed ID: 9815730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
